Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1958
website : www.cdibp.com
Main Product : Vaccines, blood products, and diagnostic reagents
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a renowned biopharmaceutical company with a history dating back to 1958. They specialize in the production of vaccines, blood products, and diagnostic reagents, serving both the domestic and international markets. With a large workforce of over 500 employees, the company is known for its high-quality products and is considered a key player in the biopharmaceutical industry in China.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Changchun Institute of Biological Products Co., Ltd.
Establishment time : Changchun Institute of Biological Products Co., Ltd. was founded in 1958.
website : http://www.cibp.cicp.ac.cn/.
Main Product : Their main products include vaccines and biological products.
Company Profile
Changchun Institute of Biological Products Co., Ltd. is known for its high-quality vaccines and innovative research in the biological products sector.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : Wuhan Institute of Biological Products Co., Ltd. was founded in 1965 and has since become a leading player in the vaccine industry.
website :
Main Product : With a large company size, Wuhan Institute of Biological Products Co., Ltd. serves both domestic and international markets.
Company Profile
Overall, Wuhan Institute of Biological Products Co., Ltd. is a trusted and reliable provider of vaccines, contributing to public health and disease prevention efforts worldwide.
Hualan Biological Engineering Inc.
Establishment time : Hualan Biological Engineering Inc. was founded in 1993 and has since become a leading biopharmaceutical company in China.
website :
Main Product : With over 3,000 employees, Hualan Biological Engineering Inc. is a large company with a strong presence in the market.
Company Profile
Overall, Hualan Biological Engineering Inc. is committed to improving public health through the development of safe and effective biopharmaceutical products.
June 29, 2024
